Exact Sciences Shareholders Approve Abbott Merger, Reject Executive Pay Plan
At the Feb. 23 special meeting, Exact Sciences stockholders approved the merger agreement with Abbott, advancing the acquisition process. A separate vote on the executive compensation proposal failed, rejecting the proposed pay package for the combined company’s leadership.
1. Merger Approval
At a Feb. 23 special meeting, Exact Sciences stockholders voted to approve the merger agreement with Abbott, marking a key governance milestone and propelling the acquisition process forward.
2. Executive Pay Defeat
Shareholders cast a separate ballot on the executive compensation proposal and rejected the plan, blocking the intended pay structure for post-merger leadership and signaling concerns over leadership incentives.
3. Next Steps
With shareholder consent secured, Exact Sciences and Abbott will proceed with required regulatory filings and work toward finalizing a closing schedule, while management must revisit and revise the defeated compensation framework.